Details for New Drug Application (NDA): 215618
✉ Email this page to a colleague
NDA 215618 describes ATROPINE SULFATE, which is a drug marketed by Us Army, Amneal, Apotex, Bausch And Lomb Inc, Edenbridge Pharms, Mankind Pharma, Rising, Somerset, Somerset Theraps Llc, Accord Hlthcare, Am Regent, Hikma, Hospira, Intl Medication Sys, Medefil Inc, and Fresenius Kabi Usa, and is included in twenty-two NDAs. It is available from twenty-five suppliers. Additional details are available on the ATROPINE SULFATE profile page.
The generic ingredient in ATROPINE SULFATE is atropine sulfate. There are twenty-three drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the atropine sulfate profile page.
The generic ingredient in ATROPINE SULFATE is atropine sulfate. There are twenty-three drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the atropine sulfate profile page.
Summary for 215618
| Tradename: | ATROPINE SULFATE |
| Applicant: | Somerset Theraps Llc |
| Ingredient: | atropine sulfate |
| Patents: | 0 |
Pharmacology for NDA: 215618
| Mechanism of Action | Cholinergic Antagonists Cholinergic Muscarinic Antagonists |
Suppliers and Packaging for NDA: 215618
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ATROPINE SULFATE | atropine sulfate | SOLUTION/DROPS;OPHTHALMIC | 215618 | ANDA | Somerset Therapeutics, LLC | 70069-581 | 70069-581-01 | 1 BOTTLE in 1 CARTON (70069-581-01) / 2 mL in 1 BOTTLE |
| ATROPINE SULFATE | atropine sulfate | SOLUTION/DROPS;OPHTHALMIC | 215618 | ANDA | Somerset Therapeutics, LLC | 70069-582 | 70069-582-01 | 1 BOTTLE in 1 CARTON (70069-582-01) / 5 mL in 1 BOTTLE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 1% | ||||
| Approval Date: | Jul 1, 2024 | TE: | AT1 | RLD: | No | ||||
Complete Access Available with Subscription
